IDiyas

For the Inventor, By the Inventor

Shanghai, China

Xiufang Zheng

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal18 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):
1. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease (2023-04-03),
2. 11242345 - Sulfonimidoylpurinone compounds and methods of treatment using the same (2022-02-08),
3. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection (2021-11-23),
4. 10975098 - Substituted aminothiazolopyrimidinediones for the treatment of virus infection (2021-04-13),
5. 10752630 - 7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection (2020-08-25),
6. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection (2020-04-14),
7. 10590146 - Substituted aminothiazolopyrimidinediones (2020-03-17),
8. 10399983 - Sulfonimidoylpurinone compounds (2019-09-03),
9. 10233184 - 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection (2019-03-19),
10. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection (2019-01-29),
11. 10065973 - Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection (2018-09-04),
12. 10040815 - 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection (2018-08-07),
13. 9890155 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection (2018-02-13),
14. 9708325 - Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection (2017-07-18),
15. 9670211 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection (2017-06-06),

Title: Inventor Spotlight: Xiufang Zheng

Introduction: Meet Xiufang Zheng, a prolific inventor based in Shanghai, China, with a remarkable portfolio of 18 patents. His groundbreaking work in developing compounds for the treatment and prophylaxis of respiratory syncytial virus disease has garnered global attention.

Latest Patents: Zheng's latest patents include innovative compounds designed for combatting respiratory syncytial virus disease. These compounds, such as those of formula (I), exhibit promising pharmaceutical properties and hold immense potential in revolutionizing the treatment and prevention of this prevalent illness.

Career Highlights: Throughout his career, Xiufang Zheng has made significant contributions to the field of pharmaceuticals and biochemistry. He has showcased his expertise while working at renowned companies such as Hoffmann-La Roche Inc., where he has spearheaded groundbreaking research initiatives and pioneered novel drug development strategies.

Collaborations: Zheng's success is also attributed to his collaborative nature. He has worked closely with esteemed peers in the industry, including colleagues like Hongying Yun and Lisha Wang. Together, they have synergized their talents to drive innovation and push the boundaries of scientific discovery.

Conclusion: Xiufang Zheng's dedication to advancing healthcare through inventive pharmaceutical solutions is truly commendable. His relentless pursuit of excellence and his remarkable contributions to the field underscore his status as a visionary inventor shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…